Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

Clinical trial NCT06949956 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06949956
Sponsor: Elpen Pharmaceutical Co. Inc.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2025-06-01
Primary completion: 2027-12-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.